The store will not work correctly when cookies are disabled.
5-(4-fluorophenyl)-1-hexyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridine
ID: ALA4287600
PubChem CID: 145991832
Max Phase: Preclinical
Molecular Formula: C17H23FN4
Molecular Weight: 302.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCn1nnc2c1CCN(c1ccc(F)cc1)C2
Standard InChI: InChI=1S/C17H23FN4/c1-2-3-4-5-11-22-17-10-12-21(13-16(17)19-20-22)15-8-6-14(18)7-9-15/h6-9H,2-5,10-13H2,1H3
Standard InChI Key: JEAFHNVAOSBOSK-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
16.7716 -11.6059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5735 -11.4329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8236 -10.6587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6213 -10.4898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8715 -9.7114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6692 -9.5426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5216 -12.3801 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0037 -13.0444 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5216 -13.7085 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7394 -13.4561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0335 -13.8687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3234 -13.4561 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3234 -12.6343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0335 -12.2293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7394 -12.6328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6180 -13.8607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9086 -13.4483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1929 -13.8529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1929 -14.6679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9024 -15.0844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6180 -14.6817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4890 -15.0755 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
11 10 1 0
12 11 1 0
12 13 1 0
14 13 1 0
15 14 1 0
10 15 2 0
7 15 1 0
16 12 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
16 21 1 0
19 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 302.40 | Molecular Weight (Monoisotopic): 302.1907 | AlogP: 3.56 | #Rotatable Bonds: 6 |
Polar Surface Area: 33.95 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.56 | CX LogP: 4.02 | CX LogD: 4.02 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.77 | Np Likeness Score: -1.76 |
References
1. Karypidou K, Ribone SR, Quevedo MA, Persoons L, Pannecouque C, Helsen C, Claessens F, Dehaen W.. (2018) Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents., 28 (21): [PMID:30286952] [10.1016/j.bmcl.2018.09.019] |